GOLGA7

Across TCGA pan-cancer cohorts, GOLGA7 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated GOLGA7 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher GOLGA7 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOLGA7 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

COAD, HNSC, and CCRCC are the cancer types where GOLGA7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Quartile	All	0.794	1.000	.011	78	view →
HNSC	DFS	Tertile	II,III,IV	0.813	0.503	.003	28	view →
CCRCC	DFS	Tertile	III,IV	0.198	0.887	.010	19	view →
PDAC	DFS	Quartile	All	0.174	0.410	.007	16	view →
LSCC	DFS	Median	II,III,IV	1.000	0.840	.007	13	view →
UCEC	OS	Median	All	0.987	0.906	.027	6	view →
GBM	OS	Median	All	0.239	0.540	.016	4	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

GOLGA7–COAD (DFS)

Open the COAD breakdown →